Wu Jiapeng, Yu Jie, Cheng Zhigang, Han Zhiyu, Yu Xiaoling, Li Kai, Hu Ping, Liu Fangyi, Liang Ping
Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.
State Key Laboratory of Kidney Disease, The Chinese PLA General Hospital, Beijing, China.
Front Oncol. 2020 Sep 18;10:521349. doi: 10.3389/fonc.2020.521349. eCollection 2020.
Ureteral stenosis after percutaneous microwave ablation (MWA) of renal tumor is a rare but severe complication, and its risk factors are not apparent.
This study aimed to investigate the risk factors for stenosis of ureter after MWA treatment of the renal tumor that is a rare complication.
Data of 211 patients who underwent MWA for the treatment of renal tumor were retrospectively analyzed from September 2006 to August 2019. Demographic characteristics, clinical features, ablation parameters, and outcomes were analyzed to find out the potential risk factors of this complication. < 0.05 is considered significant.
Six of 211 patients developed ureter stenosis, and the rate of this complication is 2.84%. The median time of emergence of hydronephrosis was 226 (range, 3-390) days. Univariate analysis shows the distance between ureter and tumor ( = 0.225) or ablation zone ( = 0.089) is not related to this complication. Postoperative urine routine (red blood cell, = 0.001; white blood cell, = 0.035) and R.E.N.A.L. score ( < 0.001) is related to this complication. But after multivariate logistic analysis, only R.E.N.A.L. score ( = 0.004) is associated with this complication. The location and growth pattern of tumor and the energy of ablation were not related to this complication independently.
The stenosis of the ureter after MWA of renal tumor is not associated with the tumor size, location, or the distance between the ureter and tumor and ablation site independently. But R.E.N.A.L. score is associated with ureter stenosis after MWA for the treatment of renal tumor, which combines the information of location, depth, and size of tumor. Preoperative evaluation of the tumor is necessary for avoiding ureter stenosis. Further studies should focus on these risk factors of this complication.
肾肿瘤经皮微波消融(MWA)术后输尿管狭窄是一种罕见但严重的并发症,其危险因素尚不明确。
本研究旨在探讨肾肿瘤MWA治疗后输尿管狭窄这一罕见并发症的危险因素。
回顾性分析2006年9月至2019年8月期间211例行MWA治疗肾肿瘤患者的数据。分析人口统计学特征、临床特征、消融参数及结局,以找出该并发症的潜在危险因素。P<0.05被认为具有统计学意义。
211例患者中有6例发生输尿管狭窄,该并发症发生率为2.84%。肾积水出现的中位时间为226天(范围3 - 390天)。单因素分析显示输尿管与肿瘤的距离(P = 0.225)或消融区的距离(P = 0.089)与该并发症无关。术后尿常规(红细胞,P = 0.001;白细胞,P = 0.035)及R.E.N.A.L.评分(P<0.001)与该并发症有关。但多因素logistic分析后,仅R.E.N.A.L.评分(P = 0.004)与该并发症相关。肿瘤的位置、生长方式及消融能量均与该并发症无独立相关性。
肾肿瘤MWA术后输尿管狭窄与肿瘤大小、位置或输尿管与肿瘤及消融部位的距离无独立相关性。但R.E.N.A.L.评分与肾肿瘤MWA治疗后输尿管狭窄相关,该评分综合了肿瘤的位置、深度及大小信息。术前对肿瘤进行评估对于避免输尿管狭窄很有必要。进一步研究应聚焦于该并发症的这些危险因素。